Lina Khan Gives Up the Gavel After Contentious 4 Years as FTC Chair
"To my mind, all of this public input and engagement made our work sharper and helped us really set priorities and focus on ...
PBMs made billions marking up speciality drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
FTC Prepares to Sue Largest U.S. Apartment Landlord Over Hidden Fees
The FTC is weighing a lawsuit alleging Greystar failed to disclose fees related to trash services and background checks, ...
FTC alleges PBMs cost consumers $7.3 billion marking up drug prices
The FTC released a 60-page report Tuesday targeting the biggest three pharmacy benefit managers, claiming the companies hiked the prices of specialty drugs to generate $7.3 billion in revenue from ...
Federal Trade Commission accuses Greystar of deceptive practices, hidden fees
The antitrust agency recently created a rule regarding junk fees, but its application to the multifamily sector is unclear.
GlobeSt.com4h
FTC Prepares Legal Action Against Greystar Over Hidden Rental Fees
While Greystar maintains it has been proactive in improving fee disclosures and promoting transparency, the company noted the ...
JD Supra7h
Business Groups Sue to Block Enforcement of New HSR Rule
On Friday, January 10, 2025, the Chamber of Commerce, Business Roundtable, American Investment Council, and Longview Chamber of Commerce filed ...
Hosted on MSN2h
Major PBMs Inflated Drug Prices, Pocketing $7.3 Billion Along the Way, FTC Says
The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...
Axios Vitals on MSN6h
PBMs made more than $7B marking up specialty generics: FTC
The three biggest pharmacy benefit managers made more than $7.3 billion over five years marking up the prices of specialty ...
STAT6h
FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system
For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.
Fierce Healthcare9h
FTC: Big 3 PBMs generated $7.3B from specialty generic drug markups
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...